UNSPSC 51343600: Antiviral thiosemicarbazones

Antiviral drugs made from imines derivatives.

UNSPSC 51343600 Antiviral thiosemicarbazones is a Class code showing limited direct alignment between its nominal scope and recent state and local procurement activity. The recent opportunities tagged to this code reflect a broader pattern of pharmaceutical and medical supply procurement across state health agencies, counties, and cities, but the specific products being solicited—naloxone, safe drug deactivation systems, emergency medical supplies, and generic pharmaceuticals through cooperative purchasing—do not correspond to the antiviral thiosemicarbazones category. State and local issuing bodies using similar pharmaceutical procurement structures include county health departments, state HHS commissions, municipal fire departments, and multistate cooperative purchasing alliances. The work being solicited encompasses emergency response supplies, pharmacy benefit program administration through direct-to-manufacturer channels, and bulk generic pharmaceutical distribution to member states and local facilities.

Issuing bodies soliciting under related pharmaceutical and medical supply codes span Florida counties (Seminole County), Texas state agencies (Texas Health and Human Services Commission), municipal fire and rescue services (City of Tampa), and multistate cooperative purchasing platforms (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participating jurisdictions). Recent representative opportunities include Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems with a July 26, 2023 response deadline, the City of Tampa's IFB 26P00145 for medical and first aid supplies with a March 13, 2026 deadline and an estimated contract value of $700,000, the Texas Health and Human Services Commission's RFI HHS0017013 for direct-to-manufacturer prescription programs with an April 3, 2026 response date, and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 deadline serving multiple states including Oregon. Geographic activity concentrates in the Southeast and Southwest, with multistate cooperative purchasing extending the scope across the upper Midwest. The code shows little relevant recent activity tied specifically to antiviral thiosemicarbazones as a distinct pharmaceutical class.